Royal Fund Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Royal Fund Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 08, 2024	BUY	$39.66 - $51.75 $79,320 - $103,500	2,000 New	2,000 $103,000
Q1 2024 Apr 11, 2024	SELL	$47.98 - $54.4 $9,596 - $10,880	-200 Reduced 5.71%	3,300 $178,000
Q4 2023 Feb 06, 2024	BUY	$48.48 - $57.85 $169,680 - $202,475	3,500 New	3,500 $179,000
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $369,792 - $437,886	5,400 New	5,400 $0
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $319,696 - $383,344	5,200 New	5,200 $379,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Fund Management, LLC with notifications on news.